SARA BV (NL)

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$476,042.61
Funder
European Commission
Principal Investigator
N/A
Research Location
N/A
Lead Research Institution
N/A
Research Priority Alignment
N/A

Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
Innovation
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Unspecified
Occupations of Interest
Caregivers

Abstract

Innovation: SARA is a smart healthcare robot that provides three main functionalities: (1) Improving quality of life through stimulating caretakers' mind and body and providing relaxation, (2) Decreasing workload of caretakers by taking over mundane tasks to allow caregivers to spend their time where it matters most, (3) Help contain COVID-19 disease by assisting with existing and new tasks that would otherwise extra precious human resources. Expected Results: SARA Robots have already been deployed to support several COVID-19 infected people by setting up connections to their family. With the received support, SARA plans to add several functionalities to SARA Robots to address challenges brought by COVID-19. Furthermore, the robot will support early disease detection.

Publicationslinked via Europe PMC

Last Updated:2 hours ago

View all publications at Europe PMC

Developing injury and illness epidemiology and surveillance in cycling (PhD Academy Award).

Effects of Hand-Rearing and Group Size on Chimpanzee (Pan troglodytes) Social Competence in Captivity.

Revisiting Spirituality in Physical Therapy Practice: Perceptions of US Practitioners.

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing.

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

History of Shrimp Farming and the Main Viral and Bacterial Diseases in Mexico.

Identification of Risk Factors in Patients with Recurrent Cystitis May Improve Individualized Management.

ISApl4, a New IS1595 Family Insertion Sequence Forming a Novel Pseudo-Compound Transposon That Confers Antimicrobial Multidrug Resistance in Actinobacillus pleuropneumoniae.